statistiche ricercatore

Continente	#
NA - Nord America	468
AS - Asia	257
EU - Europa	252
SA - Sud America	34
Continente sconosciuto - Info sul continente non disponibili	19
AF - Africa	16
OC - Oceania	1
Totale	1.047

Nazione	#
US - Stati Uniti d'America	451
CN - Cina	108
SG - Singapore	62
IE - Irlanda	61
DE - Germania	33
IT - Italia	33
RU - Federazione Russa	31
HK - Hong Kong	29
BR - Brasile	26
FI - Finlandia	25
VN - Vietnam	22
FR - Francia	18
UA - Ucraina	16
ZA - Sudafrica	12
IN - India	10
SE - Svezia	9
CA - Canada	8
GB - Regno Unito	8
BD - Bangladesh	5
JP - Giappone	4
MX - Messico	4
NL - Olanda	4
ES - Italia	3
IQ - Iraq	3
AR - Argentina	2
AT - Austria	2
BE - Belgio	2
CL - Cile	2
CZ - Repubblica Ceca	2
ID - Indonesia	2
JO - Giordania	2
LT - Lituania	2
PY - Paraguay	2
SA - Arabia Saudita	2
TR - Turchia	2
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BH - Bahrain	1
BY - Bielorussia	1
CO - Colombia	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
EC - Ecuador	1
EG - Egitto	1
HN - Honduras	1
JM - Giamaica	1
KE - Kenya	1
MM - Myanmar	1
MY - Malesia	1
NG - Nigeria	1
OM - Oman	1
PR - Porto Rico	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
Totale	1.029

Nome	#
Meningeal melanomatosis: a challenge for timely diagnosis.	149
Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.	145
Lingual metastasis from renal cell carcinoma: a case report and literature review.	137
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study.	136
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study	129
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias	96
Tivantinib (ARQ197) in hepatocellular carcinoma	94
Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma	93
Influence of different lipid emulsions on specific immune cell functions in head and neck cancer patients receiving supplemental parenteral nutrition: An exploratory analysis	68
Totale	1.047

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	32	0	0	0	0	0	0	3	4	1	0	3	21
2022/2023	171	15	18	2	24	18	9	0	11	69	0	4	1
2023/2024	101	5	50	0	5	3	10	2	15	0	4	2	5
2024/2025	177	2	10	5	4	1	17	3	20	49	8	19	39
2025/2026	370	31	15	42	37	49	18	63	18	40	34	17	6
2026/2027	68	6	16	23	23	0	0	0	0	0	0	0	0
Totale													1.047